Thyroid Carcinoma
1 paper
- Animals1
Trial sponsors
Company1 trialPhase 218 people
University Medical Center Groningen
1 trialPhase 430 people
Funding
1 grant since 2025National Institute on AgingUS$383.8k
Latest
7 in 12 monthsPreprints.org
Semaglutide and Papillary Thyroid Carcinoma: Current Evidence on Risk, Progression, and Mechanisms
Preprint: reviewSemaglutide
Genetics in Medicine Open
Germline POT1 variants are associated with long telomeres and an unexpected broad spectrum of malignancies
Cohort study of 44 peopleMalignancy
Polish Journal of Pathology
Suppressing Dicer inhibits proliferation and contributes to cellular senescence, partially via a p21-associated senescence pathway
Study in peopleCellular senescence
Internal and Emergency Medicine
Role of GLP-1 receptor agonists in the prevention and treatment of obesity-related cancer
ReviewGLP-1 receptor agonists
Translational Cancer Research
Single-cell and bulk transcriptomic analyses identify B-cell senescence-associated biomarkers in papillary thyroid carcinoma
Cohort study in peopleBiomarkers
bioRxiv
Heterogeneous pro-inflammatory response to BRAFV600E-induced thyroid tumor development
Preprint: experiments in miceInflammation
bioRxiv
Sex differences in thyroid aging and their implications in thyroid disorders: insights from gene regulatory networks
Preprint: computational studyCell cycle regulation
ENDO 2025 Abstract
SUN-344 Much Ado About Nothing: Tirzepatide and Medullary Thyroid Cancer Debunked
Cohort study in peopleTirzepatide